美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

碧美斯

57.25

+0.0000

09月20日 16:00 美東時間

成交量：- -

成交額：- -

市值：52.22億

市盈率：22.68

高：57.25

開：57.25

低：57.25

收：57.25

分时

5日

日K

周K

月K

季K

年K

1分

5分

10分

15分

30分

1小时

2小时

更多

分时

5日

日K

周K

月K

季K

年K

1分

5分

10分

15分

30分

1小时

2小时

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

BMS拿下CAR-T明星公司！諾華、強生/傳奇、吉利德等如何接招？

医药经济报

Flux Power Holdings, Inc.盤中異動大幅拉昇5.34%

2Seventy Bio, Inc.股價拉昇76.07% 市值漲1.93億美元

BMS 2.86億美元收購2seventy，藍鳥徹底“墜落”

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BMS"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","market":"US","secType":"STK","nameCN":"碧美斯","latestPrice":57.25,"timestamp":1569009600000,"preClose":57.25,"halted":0,"volume":0,"delay":0,"changeRate":0,"change":0,"floatShares":90294980,"shares":91211989,"eps":2.609607,"lyrEps":2.480219,"pbRate":4.18,"amount":0,"amplitude":0,"dividePrice":1.28,"prevYearClose":57.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","floatShares":90294980,"roa":"--","roe":"--","lyrEps":2.480219,"shares":91211990,"dividePrice":1.28,"high":57.25,"amplitude":0,"preClose":57.25,"low":57.25,"week52Low":40.86,"pbRate":"4.18","week52High":59.85,"institutionHeld":0.7014,"latestPrice":57.25,"eps":2.5238,"divideRate":0.022358,"volume":0,"delay":0,"ttmEps":2.5238,"open":57.25,"prevYearClose":57.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-01-29","symbol":"BMS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1580274000000,"reportTimeType":"pre","actualEps":null},{"date":"2019-10-23","symbol":"BMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1571817600000,"name":null,"time":"盤前","dateTimestamp":1571803200000,"actualEps":null},{"market":"US","date":"2019-04-26","symbol":"BMS","amount":0.32,"name":"碧美斯","payableDate":"2019-04-29","currency":"USD","type":"dividend","dateTimestamp":1556251200000},{"market":"US","date":"2019-04-22","symbol":"BMS","fiscalQuarterEnding":"2019/03","expectedEps":0.66,"name":null,"time":"","type":"earning","dateTimestamp":1555905600000,"reportTimeType":"","actualEps":0.67},{"market":"US","date":"2019-02-19","symbol":"BMS","amount":0.32,"name":"碧美斯","currency":"USD","type":"dividend","dateTimestamp":1550552400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMS\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-16","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-05-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-08-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-11-14","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2018-02-16","recordDate":null,"paymentDate":null,"value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BMS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519104814","title":"BMS拿下CAR-T明星公司！諾華、強生/傳奇、吉利德等如何接招？","url":"https://stock-news.laohu8.com/highlight/detail?id=2519104814","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519104814?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 11:41","pubTimestamp":1741923700,"startTime":"0","endTime":"0","summary":"当地时间3月11日，BMS以总股权价值2.86亿美元收购2seventy公司，将双方联合开发的BCMA CAR-T细胞疗法完全纳入旗下。Abecma是BMS第二款CAR-T细胞产品。此次收购，彰显了BMS在CAR-T疗法领域的决心，也代表2seventy的完美谢幕。Abecma是BMS第二款CAR-T疗法，也是首款获得FDA批准的BCMA CAR-T疗法，获批时间为2021年3月26日，用于治疗四线以上多发性骨髓瘤。作为BMS首个上市的CAR-T产品，Breyanzi一直表现良好。面对BMS的强攻态势，诺华、吉利德、强生等又将如何应对？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314114401ab64df8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314114401ab64df8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2129689605.HKD","NVS","IE0034235303.USD","LU1585245621.USD","BMS","IE00BKVL7J92.USD","LU1066051498.USD","BK4566","LU2129689514.USD","LU1718418525.SGD","LU2430703251.USD","LU1032466523.USD","BK4581","IE0002270589.USD","LU1267930813.SGD","LU1061106388.HKD","LU1732799900.SGD","CAR","LU2505996509.AUD","LU2592432038.USD","LU0203345920.USD","LU1506573853.SGD","BK4550","LU0889565916.HKD","LU1162221912.USD","LU2468319806.SGD","GILD","IE00B7SZLL34.SGD","LU0889566641.SGD","LU0122379950.USD","LU0345769631.USD","BK4007","LU1894683264.USD","LU1929549753.HKD","IE00B4R5TH58.HKD","JNJ","IE00BJJMRZ35.SGD","LU0795875086.SGD","IE00B1BXHZ80.USD","LU0208291251.USD","LU1066053197.SGD","LU1839511570.USD","LU2347655156.SGD","LU0792757196.USD","BK4139","LU0882574055.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1280957306.USD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2518211207","title":"Flux Power Holdings, Inc.盤中異動 大幅拉昇5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518211207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518211207?lang=zh_tw&edition=fundamental","pubTime":"2025-03-12 00:14","pubTimestamp":1741709663,"startTime":"0","endTime":"0","summary":"北京时间2025年03月12日00时14分，Flux Power Holdings, Inc.股票出现波动，股价大幅拉升5.34%。Flux Power Holdings, Inc.股票所在的电气设备零件行业中，整体涨幅为1.65%。Flux Power Holdings, Inc.公司简介：Flux Power Holdings Inc设计、开发、制造和销售一系列锂离子储能解决方案，用于一系列工业和商业领域的电气化，包括物料处理、机场地面支持设备和其他商业和工业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312001423ab5e2473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312001423ab5e2473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMS","FLUX","BK4096"],"gpt_icon":0},{"id":"2518741971","title":"2Seventy Bio, Inc.股價拉昇76.07% 市值漲1.93億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518741971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518741971?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 21:30","pubTimestamp":1741699824,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日21时30分，2Seventy Bio, Inc.股票出现异动，股价大幅拉升76.07%。2Seventy Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。2Seventy Bio, Inc.公司简介：2seventy bio Inc 是一家细胞和基因治疗公司，专注于癌症变革性治疗的研究、开发和商业化。此次收购也标志着2seventy bio旅程的终结，蓝鸟彻底“坠落”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213025ab5de810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213025ab5de810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMS","TSVT","BK4139"],"gpt_icon":0},{"id":"2518745656","title":"BMS 2.86億美元收購2seventy，藍鳥徹底“墜落”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745656","media":"新浪医药","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518745656?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 19:55","pubTimestamp":1741694122,"startTime":"0","endTime":"0","summary":"交易预计将在2025年第二季度完成。2seventy bio管线中有多款CAR-T细胞疗法产品，其中Abecma由BMS合作开发和商业化，已在2021年获批上市。据BMS财报，2024年Abecma销售额为4.06亿美元。2024年6月时2seventy bio宣布，诺和诺德已经花费4000万美元购买了2seventy bio的血友病A项目，以及该生物技术用于自身免疫疾病的一些基因编辑技术的权利。作为与BMS推出BCMA-CAR-T Abecma的业内先驱，2seventy在两次业务出售后，也只剩下了 Abecma本身。此次收购也标志着2seventy bio旅程的终结，蓝鸟彻底“坠落”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311202840a1d4fe39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311202840a1d4fe39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMS","BK4139","TSVT"],"gpt_icon":0}],"pageSize":4,"totalPage":26,"pageCount":1,"totalSize":104}]}}

如果下載按鈕點擊無跳轉，請點擊右上角菜單選擇 “在瀏覽器打開”

立即諮詢
下載APP
掃碼下載APP